Beyond Air, Inc. — Director's Dealing 2022

Jul 5, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Beyond Air, Inc. (XAIR)
CIK: 0001641631
Period of Report: 2022-06-30

Reporting Person: Avniel Amir (Director, COO and President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-30	Common Stock	S	65500	$6.5035	Disposed	408027	Direct
2022-06-30	Common Stock	S	2600	$6.5746	Disposed	13733	Indirect

Footnotes

F1: The sale was made to satisfy an Israeli tax obligation resulting from the reporting person's ownership of shares of Advanced Inhalation Therapies (AIT) Ltd., an Israeli corporation, which merged with Beyond Air, Inc. (formerly known as AIT Therapeutics, Inc.), a Delaware corporation, on January 13, 2017.

F2: The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.47 to $6.59, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

F3: The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.57 to $6.585, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.